Literature DB >> 7971718

Uptake of nanoparticles by rat glomerular mesangial cells in vivo and in vitro.

L Manil1, J C Davin, C Duchenne, C Kubiak, J Foidart, P Couvreur, P Mahieu.   

Abstract

Glomerular mesangial cells play a major role in the structure of capillary loops, generation of mediators of inflammation, and uptake of macromolecules. We demonstrate here that isobutylcyanoacrylate nanoparticles loaded with actinomycin D (ADNP) concentrate in rat mesangial cells in vitro and in vivo, as compared to the free drug (AD). In normal rats injected with 20 micrograms of 3H-ADNP or 3H-AD, the uptake ratios 3H-ADNP/3H-AD measured in whole kidneys at 30 and 120 min were 2.2 +/- 1.0 and 2.3 +/- 0.9, respectively. The same ratios calculated for isolated rat glomeruli and tubules, were 4.1 +/- 0.5 and 0.8 +/- 0.2 at 30 min, and 2.6 +/- 0.5 and 0.6 +/- 0.3 at 120 min, respectively. In the glomeruli, the absolute uptake of 3H-ADNP corresponded to 7.5 (30 min) and 1.8 (120 min)% I.D./100 mg of protein. In rats with experimental glomerulonephritis, the uptakes of 3H-ADNP and 3H-AD by the glomeruli were 6.9 and 4.0 times higher than in normal rats, respectively. In vitro experiments demonstrated up to 5 times higher uptake by glomerular mesangial cells than by epithelial cells. Uptake was maximum after 60 min, higher at 37 degrees C than at 4 degrees C, dependent on the presence of fresh serum and inhibited by cytochalasin-B. Drug targeting by nanoparticles is thus possible to renal cells involved in inflammatory processes, especially mesangial cells and macrophages. Nanoparticles could also be useful for lowering drug concentration in tubular cells, to reduce any tubular toxicity.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7971718     DOI: 10.1023/a:1018993000633

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  16 in total

1.  Isobutyl cyanoacrylate nanoparticles as a solid phase for an efficient immunoradiometric assay.

Authors:  L Manil; L Roblot-Treupel; P Couvreur
Journal:  Biomaterials       Date:  1986-05       Impact factor: 12.479

2.  Adsorption of antineoplastic drugs to polyalkylcyanoacrylate nanoparticles and their release in calf serum.

Authors:  P Couvreur; B Kante; M Roland; P Speiser
Journal:  J Pharm Sci       Date:  1979-12       Impact factor: 3.534

3.  Mesangial fenestrations, sieving, filtration, and flow.

Authors:  H Latta; S Fligiel
Journal:  Lab Invest       Date:  1985-06       Impact factor: 5.662

4.  Toxicity of polyalkylcyanoacrylate nanoparticles II: Doxorubicin-loaded nanoparticles.

Authors:  P Couvreur; B Kante; L Grislain; M Roland; P Speiser
Journal:  J Pharm Sci       Date:  1982-07       Impact factor: 3.534

5.  Hepatic tissue distribution of doxorubicin-loaded nanoparticles after i.v. administration in reticulosarcoma M 5076 metastasis-bearing mice.

Authors:  N Chiannilkulchai; N Ammoury; B Caillou; J P Devissaguet; P Couvreur
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 6.  Cell culture approaches to the analysis of glomerular inflammation.

Authors:  D H Lovett; R B Sterzel
Journal:  Kidney Int       Date:  1986-08       Impact factor: 10.612

7.  Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance.

Authors:  C Cuvier; L Roblot-Treupel; J M Millot; G Lizard; S Chevillard; M Manfait; P Couvreur; M F Poupon
Journal:  Biochem Pharmacol       Date:  1992-08-04       Impact factor: 5.858

Review 8.  The glomerular mesangial cell: an expanding role for a specialized pericyte.

Authors:  D Schlondorff
Journal:  FASEB J       Date:  1987-10       Impact factor: 5.191

9.  Reactive oxygen production by cultured rat glomerular mesangial cells during phagocytosis is associated with stimulation of lipoxygenase activity.

Authors:  L Baud; J Hagege; J Sraer; E Rondeau; J Perez; R Ardaillou
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

10.  A mononuclear cell component in experimental immunological glomerulonephritis.

Authors:  G F Schreiner; R S Cotran; V Pardo; E R Unanue
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

View more
  12 in total

1.  A kidney-selective biopolymer for targeted drug delivery.

Authors:  Gene L Bidwell; Fakhri Mahdi; Qingmei Shao; Omar C Logue; Jamarius P Waller; Caleb Reese; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2016-10-26

2.  Size-dependent bioadhesion of micro- and nanoparticulate carriers to the inflamed colonic mucosa.

Authors:  A Lamprecht; U Schäfer; C M Lehr
Journal:  Pharm Res       Date:  2001-06       Impact factor: 4.200

Review 3.  Mesangial pathology in glomerular disease: targets for therapeutic intervention.

Authors:  Yogesh M Scindia; Umesh S Deshmukh; Harini Bagavant
Journal:  Adv Drug Deliv Rev       Date:  2010-09-07       Impact factor: 15.470

4.  The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers.

Authors:  Mohamed G Qaddoumi; Hideo Ueda; Johnny Yang; Jasmine Davda; Vinod Labhasetwar; Vincent H L Lee
Journal:  Pharm Res       Date:  2004-04       Impact factor: 4.200

5.  Acute renal toxicity of doxorubicin (adriamycin)-loaded cyanoacrylate nanoparticles.

Authors:  L Manil; P Couvreur; P Mahieu
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

6.  Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.

Authors:  Sandhya Pranatharthiharan; Mitesh D Patel; Vinod C Malshe; Vaishali Pujari; Ajit Gorakshakar; Manisha Madkaikar; Kanjaksha Ghosh; Padma V Devarajan
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

7.  Modified paclitaxel-loaded nanoparticles for inhibition of hyperplasia in a rabbit arterial balloon injury model.

Authors:  Lin Mei; Hongfan Sun; Xu Jin; Dunwan Zhu; Rui Sun; Minfang Zhang; Cunxian Song
Journal:  Pharm Res       Date:  2007-03-20       Impact factor: 4.580

8.  The potential risks of nanomaterials: a review carried out for ECETOC.

Authors:  Paul J A Borm; David Robbins; Stephan Haubold; Thomas Kuhlbusch; Heinz Fissan; Ken Donaldson; Roel Schins; Vicki Stone; Wolfgang Kreyling; Jurgen Lademann; Jean Krutmann; David Warheit; Eva Oberdorster
Journal:  Part Fibre Toxicol       Date:  2006-08-14       Impact factor: 9.400

9.  In vitro effects of nanoparticles on renal cells.

Authors:  Béatrice L'azou; Joana Jorly; Dinhill On; Elisabeth Sellier; Frédéric Moisan; Jocelyne Fleury-Feith; Jean Cambar; Patrick Brochard; Céline Ohayon-Courtès
Journal:  Part Fibre Toxicol       Date:  2008-12-19       Impact factor: 9.400

Review 10.  Application of Advanced Nanomaterials for Kidney Failure Treatment and Regeneration.

Authors:  Aziz Eftekhari; Solmaz Maleki Dizaj; Elham Ahmadian; Agata Przekora; Seyed Mahdi Hosseiniyan Khatibi; Mohammadreza Ardalan; Sepideh Zununi Vahed; Mahbuba Valiyeva; Sevil Mehraliyeva; Rovshan Khalilov; Mohammad Hasanzadeh
Journal:  Materials (Basel)       Date:  2021-05-29       Impact factor: 3.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.